Explore the critical question of screening at-risk groups for Helicobacter pylori in this 21-minute conference talk from the 2022 Gastric Cancer Summit. Presented by Dr. Meira Epplein from Duke University, delve into the relationship between H. pylori infection and gastric cancer. Examine infection-associated cancers, trends in gastric cancer rates, and current ACG guidelines. Learn about ongoing research projects, including the Grace team's work, and discover preliminary data on using antibodies for screening. Gain insights into the big questions surrounding H. pylori screening and understand potential future directions in this field of gastroenterology.
Should We Be Screening At-Risk Groups for H. pylori? - 2022 Gastric Cancer Summit
Stanford Department of Medicine via YouTube
Overview
Syllabus
Intro
Presentation
Infection Associated Cancer
What are infections causing cancer
What is Helicobacter pylori
Chronic Helicobacter pylori infection
Trends in gastric cancer
H pylori and gastric cancer
How do we target those at highest risk
ACG guidelines
Randomized controlled trial
Grace team
Big questions
Project overview
Project results
Project digest
Preliminary data
Using antibodies for screening
What is next
Taught by
Stanford Department of Medicine
